Topic Archives: DocGumshoe

[Ed note: Following is another installment from our favorite medical scribe, “Doc Gumshoe” (no, he’s not a doctor). We feature Michael’s commentary every couple weeks or so, and his thoughts and words are his own. “Doc” doesn’t pick stocks, but FDA decisions are a huge driver of investment success for pharmaceutical and biotech companies and […]

Robert Morris is helming a biotech-focused stock newsletter that’s called Biotech Supertrader (modesty has no place in the world of newsletter promotions, of course), and I’ve never covered this letter before so I thought I ought to have a look at the latest teaser we’ve been asked about. Morris, incidentally, has been featured in our […]

[ed note: We feature the musings of our favorite health and medicine writer, Michael Jorrin, a couple times a month, and we’ve taken the liberty of calling him “Doc Gumshoe” (he’s not a doctor). You’ll find no stock picks in his pieces, but hopefully will get plenty of insight into the medical matters he explains […]

Today we’re sharing another piece from our medical contributor, “Doc Gumshoe” — we have added the stock tickers to the companies he mentions for your researching convenience, but this survey of the state of cancer research — which will hopefully be good background help to folks trying to understand the basic science behind pitches for […]

The one area of the web that has as many “self help” and “miracle solutions” newsletters (and marketing teasers) as personal finance is health — the investing newsletters promise eternal wealth, and the health newsletters promise eternal life (or something dang close). Readers ask us about the crazy marketing for these health newsletters all the […]

Comments

  • @docgumshoe "I can’t think of a single thing that our friend could have done to prevent the development of AD. " ...

  • I did not see how to post this to Doc other than by commenting here; sorry. This link describes good preliminary resu...

  • I've been following Gumshoe for about 7 years and about the same with Avi Gilburt, and over the past few years joined hi...

  • DocGumshoe may want to include some mention of 'challenge' trials, what they are, how they're supposed to work and the e...

  • Cytodyn will be reporting on P2 M2M results within 2 weeks, and DSMC is taking a look at their S/C P2b/P3 trial this wee...

  • This was immensely interesting as my mother has Alzheimer’s. You do not mention anywhere the research carried out by D...

  • Gotta say, from all the memberships I need to pay for (think; Netflix, Spotify, Apple News+, Hulu, Barron's...) the one ...

  • Excellent article Doc Gumshoe! We really appreciate all of your efforts to educate us and keep us informed and abrea...

  • "News about the effectiveness / ineffectiveness of the current flu vaccine has been spread far and wide, with the result...

  • #ZKSS http://www.stockgumshoe.com/author/dr-kss-md-phd/ and #DocGumshoe http://www.stockgumshoe.com/author/mjorrin/ hav...

  • Many thanks to all the readers of yesterday’s DocGumshoe piece. I’ve noted down your questions & will try to a...

  • Dear DocGumshoe, First of all ~ welcome to the Gumshoe reading family. The subject you are focusing on is vast and the...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info